Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 4
1(25.0%)
4Total
N/A(3)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07450365Phase 4Not Yet Recruiting

Evaluation of Long-term Efficacy of 4 to 6-month Course Antiviral Therapy for Neurodevelopmental Impairments Caused by Congenital Cytomegalovirus Infection

Role: collaborator

NCT06938464Not ApplicableRecruiting

Preventive Effect of Probiotics in GDM

Role: collaborator

NCT04801485Not ApplicableCompleted

D-chiro Inositol in Prevention of Gestational Diabetes Mellitus in China

Role: collaborator

NCT05003154Not ApplicableUnknown

Digitalized Management Exploration for Gestational Diabetes Mellitus in China

Role: collaborator

All 4 trials loaded